ARCT has a multiple top, and is currently at resistance. Even if you want to trade it with a mean-reversion strategy, you could still wait until it goes down to a support level. I highlighted three support levels. If you are a momentum trader, you can wait until it goes down to support, and then short it, right before it breaks below. Thanks.
I expect a nice move up on this. I just randomly picked it, so know nothing about it. However, it's suggested through my dowsing and intuitive method that it will pull back after the initial spring up.
Potential long above $63.00 Upside Fibonacci target zone $76.00
today will be the decider, do i grab calls or not, play the chart
Engages in the research and development of medical applications for the nucleic acid-focused technology. The firm develops RNA therapeutics which focuses on the treatment of liver and respiratory diseases. Its pipeline include LUNAR-OTC and LUNAR CF . as of 3 days the ascending volatile is going thoroughly. and even were facing the pandemic, the company still on...
over 41 no resistance until 68,100,200... this could be a crazy squeeze next week
we wait the close of any close bulish candel
Hello Everyone, The stock (ARCT) appears to have been oversold within the last week few weeks of March. Considering an imminent rejection may take place. Be cautious of the value (either an immediate rejection) or a pull up towards (7.15-7.30) and then bearish momentum. Not Investment Advice. For Educational and Analytical Purposes Only. (Be Aware and Stick To...
ARCT has been trading sideways for the better part of two months. In addition, it has recently exhibited a large spike in buy-back volume. This comes after a news report that states that Arcturus Therapeutics announced a “broad strategic collaboration to advance next generation of lipid-mediated mRNA therapeutics”. Moreover, the RSI has shown a drastic spike in...